# Single-step Antigen Loading and TLR Activation of Dendritic Cells in Melanoma Patients

> **NCT01530698** · PHASE1,PHASE2 · COMPLETED · sponsor: **Radboud University Medical Center** · enrollment: 28 (actual)

## Conditions studied

- Melanoma

## Interventions

- **BIOLOGICAL:** autologous dendritic cell vaccine
- **BIOLOGICAL:** autologous dendritic cell vaccine

## Key facts

- **NCT ID:** NCT01530698
- **Lead sponsor:** Radboud University Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-04
- **Primary completion:** 2014-11
- **Final completion:** 2014-11
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2017-04-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01530698

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01530698, "Single-step Antigen Loading and TLR Activation of Dendritic Cells in Melanoma Patients". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT01530698. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*